Global Protein Engineering Market Hits $3.5 billion in 2025 with 16.4% CAGR

Global protein engineering market was valued at $3.5 billion in 2025 and is growing at a CAGR of 16.4% during the forecast period (2026-2035). Increasing investments in R&D for monoclonal antibodies, engineered proteins, and next-generation biologics are driving market growth and fueling demand for efficient protein engineering solutions. Additionally, this trend is reflected in recent funding activities that support the development of integrated, in-house protein engineering and validation capabilities aimed at accelerating antibody and biologics discovery. For instance, in January 2026, Nuclera successfully extended its Series C funding to a total of $87 million, including an additional $12 million financing extension aimed at enhancing its eProtein Discovery capabilities for antibody engineering. The funding, led by Elevage Medical Technologies and Jonathan Milner, alongside existing investors, will focus on integrating antibody expression and binding validation into Nuclera's benchtop eProtein Discovery System. This initiative will facilitate rapid, in-house multiplex protein screening and characterization, essential for advancing AI-enabled protein engineering and meeting the industry's demands for high-quality datasets in biologics discovery.

Browse the full report description of “Protein Engineering Market Size, Share & Trends Analysis by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/protein-engineering-market

Key Innovators Driving Protein Engineering Transformation

The key players in the protein engineering market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., GenScript Biotech Corp., Thermo Fisher Scientific Inc., among others. These companies are driving innovation in digital health solutions, including telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, thereby shaping the future of healthcare delivery globally.

• In January 2026, Avenue Biosciences raised $5.7 million to advance its technology that modulates the secretory pathway, crucial for the enhanced production of therapeutic proteins. This funding will support scaling the technology that produces thousands of protein variants, surpassing current industry standards in both yield and quality. The innovation paves the way for new therapeutic targets in cancer care, infectious diseases, and immunology, facilitating faster access to a range of treatments, including antibodies, vaccines, AI-designed proteins, and gene therapies.
• In August 2025, NSF has announced a nearly $32 million investment to support five teams in the U.S. through the NSF Use-Inspired Acceleration of Protein Design initiative. This initiative aims to enhance the use of AI in protein design, facilitating new applications that are vital to the U.S. bioeconomy.
• In December 2024, Cradle Bio raised $73 million in a Series B funding round, increasing its total funding to over $100 million. The company focuses on making AI-powered protein engineering more accessible to researchers. Utilizing advanced machine learning alongside experimental data, Cradle Bio's platform aims to design and optimize proteins tailored for specific functions and properties.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Protein Type
  • By Product
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., GenScript Biotech Corp., Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Protein Engineering Market Report Segment

By Protein Type

• Monoclonal Antibodies
• Insulin
• Erythropoietin
• Interferon
• Colony Stimulating Factor
• Coagulation Factor
• Vaccines
• Others (Growth Hormones)

By Product

• Instruments
• Service and Software
• Reagents

By End-User

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)

Global Protein Engineering Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/protein-engineering-market